Chemren Bio-Engineering Co., Ltd.

Serdemetan(JNJ 26854165)

Serdemetan(JNJ 26854165)

Description of:Serdemetan
Serdemetan(JNJ 26854165) is an orally bioavailable, first-in-class small-molecule HDM2 antagonist with potential anti...
More>>
Total: 1 Page: 1 / 1 First ←Previous Next→ End

Online service

点击这里给我发消息